is semaglutide on the fda shortage list How Crackdowns Are Affecting GLP-1 Use In 2025 FDA declares semaglutide (Ozempic/Wegovy) shortage

Liraglutide is a daily GLP1 receptor agonist (marketed as Saxenda for weight loss, Victoza for diabetes), while Semaglutide is a weekly GLP1 with generally greater average weight loss in trials

Supply Chain Reliability Geographic area contemplations influence shipping timelines, costs, and administrative prerequisites

The best diet for GLP-1 medications is high in protein, fiber, and healthy fats to help keep you full longer

What is known is that in one study, after 68 weeks, those who stopped this medication regained two-thirds of their prior weight loss

Administering the injection on the same day each week helps maintain consistent medication levels, which supports both effectiveness and tolerability

Because these are prescription medications, they are also taken under the supervision of a knowledgeable healthcare provider, who can monitor patients for side effects and other health complications